
LEITAT @ Kick-off meeting of LIFE+ project MERMAIDS
LEITAT, along with all the partners of the MERMAIDS project, met at the Italian National Research Council (CNR) in Pozzuoli
LEITAT, along with all the partners of the MERMAIDS project, met at the Italian National Research Council (CNR) in Pozzuoli
Last February, Bart Bosveld, executive director of the Society of Environmental Toxicology and Chemistry (SETAC) – Europe, visited LEITAT alongside
To celebrate REWAGEN’s 2 years anniversary, the promotional video has been released. REWAGEN partners are jointly developing a wastewater treatment
Last 18th of June the EU Commission published the main funding scheme for Environmental projects. The total budget for this
TTPPP Application of the Transmembrane Therapeutic Protein Production Platform (TTPPP) to an innovative approach for the Treatment of Cancer or
NEQAM Development and Application of new Chemometric Strategies for Metabolomic Analysis ABSTRACT NEQAM project aims at the development, assessment and
ACINETOCLINIC Transition to Clinical Investigation Phase for Licencing of the First Vaccine Against Drug Resistent Acinetobacter Baumannii ABSTRACT Vaccines against
IDP4MM Development of drugs in new therapeutic IDP targets for the treatment of multiple myeloma ABSTRACT This project is part
The EC e-magazine CORDIS Express has devoted its latest issue to looking at a range of 8 research projects focused
TOXAB Development of Novel, Safe and Affordable Cytotoxic Antibodies for the Treatment of Cancer ABSTRACT The main objective of the
NUEVAS DIANAS Discovery and combination of new treatments for cancer treatment based on the modulation of epigenetic targets and adenosine
MICROALMABS Validation of a New Platform for Production of Therapeutic Monoclonal Antibodies with Microalgae ABSTRACT The objective of the present
METASTASIS Anti-tumor and anti-metastasis activity of monoclonal antibodies in animal models of human cancers ABSTRACT The limited effectiveness of approved
On the 18th of July LEITAT held the first Workshop of the European Project BOHEALTH. Several centers and institutions of
MatHero partners met for the 6-month progress meeting in Cambridge, United Kingdom. During this meeting, the consortium overviewed the results
KET (Key Enabling Technologies) are recognised as the driving force in the framework of Horizon 2020. They enable us to
Tel. (+34) 937 882 300
Utilitzem cookies per millorar la teva experiència de navegació, publicar anuncis o contingut personalitzats i analitzar el nostre trànsit. En fer clic a "Acceptar-ho tot", acceptes l'ús que fem de les cookies.